IPM: Summary of expert amicus briefs filed with the U.S. Supreme Court in Louisiana v. FDA supporting telehealth access to mifepristone

Anti-abortion politicians in Louisiana filed a federal lawsuit seeking to impose a nationwide restriction on mail and pharmacy access to mifepristone, a safe and effective medication used in nearly two-thirds of U.S. abortions as well as for early miscarriage care. On May 1st, a federal appeals court granted Louisiana's request, throwing abortion access across the country into turmoil. On May 4th, the Supreme Court put that ruling on hold for one week, until May 11th, while it considers whether to block it for a longer period of time, restoring patients' ability to get mifepristone through telemedicine for now.